Retracted Study on Hydrogen for Lung Cell Protection No Longer Valid
- Authors
- Yuan Li, Hongguang Chen, Ruichen Shu, Xiaobei Zhang, Yonghao Yu, Xiaofeng Liu, Kuibin Xu
- Journal
- Biochemical and Biophysical Research Communications
- Year
- 2026
- DOI
- 10.1016/j.bbrc.2026.153799
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Pulmonary Endothelial Dysfunction
- Body System
- Respiratory
TL;DR
This study about using hydrogen to treat lung damage has been taken back by scientists because the results weren't reliable—so we can't trust what it claimed to show.
Key Finding
__no_content__
Summary
A study published in Biochemical and Biophysical Research Communications that claimed hydrogen treatment could prevent lung cell damage has been officially retracted. The original research suggested hydrogen could protect pulmonary endothelial cells from lipopolysaccharide-induced dysfunction by inhibiting RhoA pathways. However, the retraction notice indicates serious issues with the study that make its findings unreliable. This means the claimed benefits of hydrogen therapy for lung protection cannot be trusted as valid scientific evidence. Researchers and clinicians should not rely on these findings when making decisions about hydrogen therapy applications for respiratory conditions.
Practical Takeaway
This study has been retracted and is no longer considered valid scientific evidence. Retracted papers should not be used to make decisions about hydrogen water or any health intervention.
Abstract
No abstract available